Who invested in LongBio Pharma?
LongBio Pharma's investors include Qiming Venture Partners, Oriental Fortune Capital and Highlight Capital.
Who invested in LongBio Pharma
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$29Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $29MMay 2025
- Investors
- 3
The rounds
- May 2025
Everyone who backed them
Highlight CapitalVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about LongBio Pharma
How much has LongBio Pharma raised?
LongBio Pharma has raised $29M across 1 round since 2025.
When did LongBio Pharma last raise?
LongBio Pharma's most recent round was a Series C of $29M in May 2025.
What was LongBio Pharma's biggest round?
Its most recent round, $29M in May 2025, is also its largest on record.
Who backed LongBio Pharma first?
LongBio Pharma's first round on record, in May 2025, was backed by Qiming Venture Partners, Oriental Fortune Capital and Highlight Capital.
What stage is LongBio Pharma at?
LongBio Pharma's latest named round is a Series C, in May 2025.
Companies like LongBio Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.